News | June 29, 2020

Iterum Therapeutics Announces Topline Results from its Phase 3 Clinical Trial of Oral Sulopenem for the Treatment of Uncomplicated Urinary Tract Infections Sulopenem demonstrates superiority in treatment of patients with quinolone resistant pathogens Company to...

News | June 23, 2020

Principia Announces First Patient Enrolled in Sanofi’s Phase 3 Trial of SAR442168 in Relapsing Multiple Sclerosis Dosing of Patient Will Trigger $50 Million Milestone Payment SOUTH SAN FRANCISCO, Calif., June 23, 2020 (GLOBE NEWSWIRE) — Principia Biopharma Inc....

News | June 23, 2020

BrightInsight Raises $40M in Series B Funding to Cement our Position as the Leading Global Regulated Digital Health Platform for Biopharma and Medtech It’s a big day for BrightInsight. Today we announced a Series B funding round of $40M led by global venture capital...

News | June 16, 2020

Inspira Health Enables More Streamlined and Seamless Access to Care with Kyruus New Jersey-Based Health System is Leveraging the Kyruus Platform to Better Manage its Network and Connect Consumers to the Right Care Boston, MA – June 16, 2020 – Kyruus, the leader in...

News | June 10, 2020

Kyruus Secures $30 Million Investment from Francisco Partners New Funding Will Accelerate Company’s Ability to Support Healthcare Organizations Caring for Patients During Unprecedented Time Boston, MA and San Francisco, CA – June 10, 2020 – Kyruus, the leader in...

News | June 15, 2020

New Research Sheds Light on Intentional Non-adherence in Clinical Trials First-of-its-kind study leverages objective adherence data collected by AiCure to illustrate scope of intentional non-adherence Study findings help inform best practices to lower non-adherence...